RAFAEL HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-04-30 was 0.00 shares.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2019-01-31 was 9.14K shares.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-10-31 was 24.05K shares.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 14.55K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-04-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | |
| 2021-07-31 | 14.55K shares 10-K · filed 2022-10-31 | |
| 2019-01-31 | 9.14K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-03-12 | |
| 2018-10-31 | 24.05K shares 10-Q · filed 2018-12-10 | |
| 2003-12-31 | 625.00K shares 10-Q · filed 2025-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |